BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 22788761)

  • 1. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
    Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
    J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
    Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
    Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
    Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
    PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
    Calpe B; Kovacs WJ
    Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production of 3D tumor spheroids for cancer drug discovery.
    Sant S; Johnston PA
    Drug Discov Today Technol; 2017 Mar; 23():27-36. PubMed ID: 28647083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer drug discovery using multicellular tumor spheroid models.
    Zanoni M; Pignatta S; Arienti C; Bonafè M; Tesei A
    Expert Opin Drug Discov; 2019 Mar; 14(3):289-301. PubMed ID: 30689452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of tumor spheroids for
    Hamilton G; Rath B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
    Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
    Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
    Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
    Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
    Lama R; Zhang L; Naim JM; Williams J; Zhou A; Su B
    Bioorg Med Chem; 2013 Feb; 21(4):922-31. PubMed ID: 23306053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?
    Friedrich J; Ebner R; Kunz-Schughart LA
    Int J Radiat Biol; 2007; 83(11-12):849-71. PubMed ID: 18058370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
    SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D in vitro tissue models and their potential for drug screening.
    Kimlin L; Kassis J; Virador V
    Expert Opin Drug Discov; 2013 Dec; 8(12):1455-66. PubMed ID: 24144315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies.
    Ong SM; Zhao Z; Arooz T; Zhao D; Zhang S; Du T; Wasser M; van Noort D; Yu H
    Biomaterials; 2010 Feb; 31(6):1180-90. PubMed ID: 19889455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging tumor spheroids technologies for 3D in vitro cancer modeling.
    Rodrigues T; Kundu B; Silva-Correia J; Kundu SC; Oliveira JM; Reis RL; Correlo VM
    Pharmacol Ther; 2018 Apr; 184():201-211. PubMed ID: 29097309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
    Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
    J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening.
    Lee JM; Park DY; Yang L; Kim EJ; Ahrberg CD; Lee KB; Chung BG
    Sci Rep; 2018 Nov; 8(1):17145. PubMed ID: 30464248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.